Chinese health officials are giving no indication of any relaxation of COVID-19 restrictions following several days of speculation the government was considering changes to a “zero-COVID” approach that has stymied economic growth and disrupted daily life.
The officials said at a news conference that they would “unswervingly” stick to the policy, which seeks to stop cases from coming into the country and snuff out outbreaks as they occur.
The announcement was not a surprise and doesn’t rule out the possibility that discussions are taking place behind closed doors. But there has been no official confirmation, and most analysts believe that any change will be gradual and major easing is unlikely until sometime next year.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Chinese officials signal no change to 'zero-COVID' policyChinese health officials are giving no indication of any relaxation of COVID-19 restrictions following several days of speculation that the government was considering changes to a “zero-COVID” approach that has stymied economic growth and disrupted daily life.
Leer más »
Chinese Shares Surge as Covid Reopening Hopes Emerge, U.S. Audit Inspections EndShares of Chinese companies listed in Hong Kong jumped after U.S. officials wrapped up an audit inspection in the city and a transcript circulated on social media suggesting China was considering reversing its strict Covid-19 policies.
Leer más »
Local doctors work to battle vaccine hesitancy in minority communities as flu, COVID case counts climbDoctors with the Cleveland Clinic are working around the clock to reduce vaccine hesitancy and take a 'boots on the ground approach' to getting shots in the arms of minority community members.
Leer más »
Pfizer, BioNTech launch phase 1 trial on combined COVID-19 and flu vaccinePfizer and BioNTech have launched a clinical trial on a vaccine targeting both COVID-19 and influenza, the companies announced Thursday.
Leer más »